Esther de Vries

7.2k total citations
146 papers, 3.2k citations indexed

About

Esther de Vries is a scholar working on Immunology, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Esther de Vries has authored 146 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Immunology, 28 papers in Epidemiology and 21 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Esther de Vries's work include Immunodeficiency and Autoimmune Disorders (44 papers), Cystic Fibrosis Research Advances (13 papers) and T-cell and B-cell Immunology (13 papers). Esther de Vries is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (44 papers), Cystic Fibrosis Research Advances (13 papers) and T-cell and B-cell Immunology (13 papers). Esther de Vries collaborates with scholars based in Netherlands, Germany and United States. Esther de Vries's co-authors include Eugenie Gemen, Ruud H J Verstegen, Maaike Kusters, Jacques J. M. van Dongen, Roeland van Hout, J. Leuvenink, Ellen Schatorjé, Wim C.J. Hop, A. Cats and Gertjan J. Driessen and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Esther de Vries

138 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Esther de Vries Netherlands 30 1.5k 622 552 542 473 146 3.2k
Julio Granados Mexico 33 1.5k 1.0× 814 1.3× 484 0.9× 390 0.7× 383 0.8× 202 4.0k
Javier Chinen United States 23 1.9k 1.3× 697 1.1× 769 1.4× 244 0.5× 492 1.0× 64 3.2k
Joseph A. Church United States 30 1.3k 0.8× 577 0.9× 642 1.2× 327 0.6× 255 0.5× 182 3.2k
Joaquı́n Zúñiga Mexico 34 1.3k 0.9× 751 1.2× 295 0.5× 326 0.6× 576 1.2× 171 3.5k
Tim Niehues Germany 31 1.5k 1.0× 598 1.0× 471 0.9× 253 0.5× 213 0.5× 153 3.3k
Arthur Weinstein United States 43 1.9k 1.2× 481 0.8× 214 0.4× 344 0.6× 431 0.9× 109 5.9k
Ann Gardulf Sweden 36 1.7k 1.1× 295 0.5× 656 1.2× 378 0.7× 519 1.1× 87 3.7k
Luiz Vicente Rizzo Brazil 46 2.4k 1.6× 1.6k 2.6× 306 0.6× 868 1.6× 209 0.4× 187 5.8k
Koert M. Dolman Netherlands 32 1.0k 0.7× 367 0.6× 326 0.6× 332 0.6× 764 1.6× 96 3.2k
Hideto Yamada Japan 38 1.5k 1.0× 1.4k 2.3× 369 0.7× 1.1k 2.1× 382 0.8× 314 6.2k

Countries citing papers authored by Esther de Vries

Since Specialization
Citations

This map shows the geographic impact of Esther de Vries's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther de Vries with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther de Vries more than expected).

Fields of papers citing papers by Esther de Vries

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esther de Vries. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther de Vries. The network helps show where Esther de Vries may publish in the future.

Co-authorship network of co-authors of Esther de Vries

This figure shows the co-authorship network connecting the top 25 collaborators of Esther de Vries. A scholar is included among the top collaborators of Esther de Vries based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esther de Vries. Esther de Vries is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wijk, Femke van, Stefan Nierkens, Rob van Binnendijk, et al.. (2025). T-cell responses to SARS-CoV-2 vaccinations in adults with Down syndrome – a prospective cohort study. Human Vaccines & Immunotherapeutics. 21(1). 2583416–2583416.
2.
3.
Vries, Esther de, et al.. (2023). Pandemic Lessons for Future Nursing Shortage: A Prospective Cohort Study of Nurses’ Work Engagement before and during 16 Months of COVID-19. Journal of Nursing Management. 2023. 1–8. 7 indexed citations
4.
Puijenbroek, Eugène van, et al.. (2023). Infections in Biological and Targeted Synthetic Drug Use in Rheumatoid Arthritis: Where do We Stand? A Scoping Review and Meta-analysis. Rheumatology and Therapy. 10(5). 1147–1165. 4 indexed citations
5.
Dahdah, Lamia, Karen Knipping, Esther de Vries, et al.. (2022). Hypoallergenicity assessment of an extensively hydrolyzed whey‐protein formula in cow’s milk allergic infants. Pediatric Allergy and Immunology. 33(6). e13814–e13814. 4 indexed citations
6.
Derijks, Hieronymus J., et al.. (2022). Dual autoencoders modeling of electronic health records for adverse drug event preventability prediction. Intelligence-Based Medicine. 6. 100077–100077. 5 indexed citations
7.
Budde, Ilona Kleine, Esther de Vries, Ineke J. M. ten Berge, et al.. (2020). Immunoglobulin Replacement Therapy Versus Antibiotic Prophylaxis as Treatment for Incomplete Primary Antibody Deficiency. Journal of Clinical Immunology. 41(2). 382–392. 14 indexed citations
8.
Peters, Vincent, et al.. (2019). Modular service provision for heterogeneous patient groups: a single case study in chronic Down syndrome care. BMC Health Services Research. 19(1). 720–720. 5 indexed citations
9.
Helm, Jannie J. van der, Maarten F. Schim van der Loeff, Esther de Vries, et al.. (2019). Vaginal herb use and Chlamydia trachomatis infection: cross-sectional study among women of various ethnic groups in Suriname. BMJ Open. 9(5). e025417–e025417. 3 indexed citations
10.
Verstegen, Ruud H J, Pei M. Aui, Sophinus J. W. Bartol, et al.. (2019). Quantification of T-Cell and B-Cell Replication History in Aging, Immunodeficiency, and Newborn Screening. Frontiers in Immunology. 10. 2084–2084. 13 indexed citations
11.
12.
Peters, Vincent, Bert Meijboom, & Esther de Vries. (2018). Interfaces in service modularity: a scoping review. International Journal of Production Research. 56(20). 6591–6606. 17 indexed citations
13.
Wojciechowski, Marek, et al.. (2017). Declining antibody levels after hepatitis B vaccination in Down syndrome: A need for booster vaccination?. Journal of Medical Virology. 89(9). 1682–1685. 11 indexed citations
14.
Driessen, Gertjan J., Virgil A. S. H. Dalm, P. Martin van Hagen, et al.. (2013). Common variable immunodeficiency and idiopathic primary hypogammaglobulinemia: two different conditions within the same disease spectrum. Haematologica. 98(10). 1617–1623. 43 indexed citations
15.
Kneepkens, C. M. F., et al.. (2013). [One guideline for diagnosing cow milk allergy; for primary, secondary and tertiary care in the Netherlands].. PubMed. 157(38). A6311–A6311. 3 indexed citations
16.
Schatorjé, Ellen, Eugenie Gemen, Gertjan J. Driessen, et al.. (2012). Paediatric Reference Values for the Peripheral T cell Compartment. Scandinavian Journal of Immunology. 75(4). 436–444. 134 indexed citations
17.
Hartley, Jane, Nicholas C. Zachos, Ban B. Dawood, et al.. (2010). Mutations in TTC37 Cause Trichohepatoenteric Syndrome (Phenotypic Diarrhea of Infancy). Gastroenterology. 138(7). 2388–2398.e2. 96 indexed citations
18.
Kusters, Maaike, et al.. (2010). IMPAIRED AVIDITY MATURATION AFTER TETANUS TOXOID BOOSTER IN CHILDREN WITH DOWN SYNDROME. The Pediatric Infectious Disease Journal. 30(4). 357–359. 20 indexed citations
19.
Hensbroek, Michaël Boele van, et al.. (2000). RASH AND PETECHIAE AS PRESENTING SIGNS OF Q FEVER. The Pediatric Infectious Disease Journal. 19(4). 358–358. 13 indexed citations
20.
Westedt, M L, Mohamed R. Daha, Esther de Vries, R. M. Valentijn, & A. Cats. (1985). IgA containing immune complexes in rheumatoid vasculitis and in active rheumatoid disease.. PubMed. 12(3). 449–55. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julio Granados Breakdown of academic impact, for papers by Javier Chinen Breakdown of academic impact, for papers by Joseph A. Church Breakdown of academic impact, for papers by Joaquı́n Zúñiga Breakdown of academic impact, for papers by Tim Niehues Breakdown of academic impact, for papers by Arthur Weinstein Breakdown of academic impact, for papers by Ann Gardulf Breakdown of academic impact, for papers by Luiz Vicente Rizzo Breakdown of academic impact, for papers by Koert M. Dolman Breakdown of academic impact, for papers by Hideto Yamada
Rankless by CCL
2026